Indian authorities are investigating more than 12 pharmaceutical firms suspected of illegally exporting pseudoephedrine to Myanmar and China. At least one of the suspects owns drug manufacturing plants in India.
Published in Brief:
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||